Skip to main content
Fig. 4 | BMC Cancer

Fig. 4

From: A text-mining approach to study the real-world effectiveness and potentially fatal immune-related adverse events of PD-1 and PD-L1 inhibitors in older patients with stage III/IV non-small cell lung cancer

Fig. 4

The safety outcomes between different age groups AĀ the overall incidence of each of the nine studied potentially fatal irAEs (nr. of patients), BĀ the percentage of patients experiencing one of the studied irAE per age subgroup and in total (%), CĀ relative risk of pooled potentially fatal irAEs (reference: patients agedā€‰<ā€‰65Ā years), DĀ relative risk of systemic corticosteroid therapy requirement during (+ā€‰6Ā months after) immunotherapy (reference: patients agedā€‰<ā€‰65Ā years

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us